Cardiovascular Systems (CSII) Reports In-Line Q3 EPS, Offers Q4 Guidance

Cardiovascular Systems (NASDAQ: CSII) reported Q3 EPS of ($0.34), in-line with the analyst estimate of ($0.34). Revenue for the quarter came in at $47 million versus the consensus estimate of $46.84 million.

Cardiovascular Systems sees Q4 2015 EPS of ($0.28)-($0.31), versus the consensus of ($0.29). Cardiovascular Systems sees Q4 2015 revenue of $49-50.5 million, versus the consensus of $50.65 million.

For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49